Tokyo, Japan

Masataka Narisada

This inventor holds 2 USPTO granted patents. Top assignee: Kaneka Corporation. Active years: 1999-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masataka Narisada. Retrieved from https://idiyas.com/inventor/masataka-narisada

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 38(Granted Patents)


Company Filing History:


Years Active: 1999-2000

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Masataka Narisada: Innovator in Blood Treatment Technologies

Introduction

Masataka Narisada is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of medical technology, particularly in blood treatment methods. With a total of 2 patents, Narisada's work focuses on improving the efficiency and safety of blood treatment processes.

Latest Patents

Narisada's latest patents include a "Method and apparatus for treating blood" and an "Extracorporeal blood circulator." The first patent addresses the challenges of pressure constraints during blood treatment. It describes a method where pump flow rates are rapidly decelerated to alleviate pressure issues, allowing the treatment to return to a normal state quickly. The second patent involves an extracorporeal blood circulator that introduces blood from the body, treats harmful substances, and returns the treated blood. Notably, the design allows for easy replacement of electrodes used for monitoring, streamlining the treatment process.

Career Highlights

Narisada is associated with Kaneka Corporation, where he continues to innovate in medical technologies. His work has garnered attention for its practical applications in healthcare, particularly in enhancing patient safety during blood treatment procedures.

Collaborations

Some of Narisada's notable coworkers include Takehisa Nakayama and Hiroshi Tachibana. Their collaborative efforts contribute to the advancement of medical technologies within their organization.

Conclusion

Masataka Narisada's contributions to blood treatment technologies exemplify the impact of innovation in healthcare. His patents reflect a commitment to improving medical procedures and patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…